Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PARP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CILP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLPX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGDCC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGDCC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBAP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASL12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC51B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTFMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HACD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on